Please login or register first to view this content.
Musculoskeletal Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Locally-Delivered Sitaxsentan Designated Orphan Drug for Systemic Sclerosis
Kineret Approved for Deficiency of IL-1 Receptor Antagonist
Continuing Treatment Not Beneficial After 5 Years of Bisphosphonates
Antifibrotic Therapy Gets Orphan Drug Status for Systemic Sclerosis
FDA to Review AVT02, a High Concentration Biosimilar to Adalimumab
RediTrex Now Available for RA, pJIA, Psoriasis Treatment
Study Supports Switching Between Upadacitinib and Adalimumab in RA
Synovitis Reduction Observed With Secukinumab in Psoriatic Arthritis Trial
Corticosteroid Exposure Affects Bone Health in Asthma Patients
Most Users Report Cannabidiol Use for Treatment of Diagnosable Conditions
Upadacitinib Tops Abatacept for RA Refractory to DMARDs
Investigational Gene Therapy Fast Tracked for Duchenne Muscular Dystrophy
Simponi Aria Approved for Polyarticular JIA, Pediatric Psoriatic Arthritis
Elezanumab Granted Orphan Drug, Fast Track Designations for Spinal Cord Injury
Gabapentin Does Not Lower Pain Scores in Chronic Pelvic Pain
Xeljanz Approved for Active Polyarticular Course Juvenile Idiopathic Arthritis
Glucocorticoids Linked to Hospitalized Infection Risk in RA
USPSTF Finds Evidence Lacking for Vitamin D Screening
